BCRB 2018

Small molecule EGFR inhibitors

IRESSA / ZD1839

Ligand

• orally bioavailable

• selective inhibitor of EGFR tyrosine kinase



ZD1839

ZD1839

• competitive inhibitor of ATP- binding

No downstream signalling







Proliferation, DNA repair, angiogenesis